Skip to content
Home/Companies/Biotech/Nephris
Nephris

Nephris

Biotech·Italy·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Nephris?

Nephris is an Italian Biotech company, currently owned by Sofinnova Partners since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Telethon · 2016 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
Websitewww.nephris.com

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)
nChroma (formerly Chroma Medicine)
Active
BiotechUS· 2022
Alia Therapeutics
Alia Therapeutics
Active
BiotechItaly· 2021
Borea Therapeutics
Borea Therapeutics
Active
BiotechItaly· 2021
AAVantgarde Bio
Active
BiotechItaly· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Nephris?

Nephris is currently owned by Sofinnova Partners, through Sofinnova Telethon, since 2022.

When did Sofinnova Partners acquire Nephris?

Sofinnova Partners acquired Nephris in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue